Related Experiment Video

Updated: Jun 2, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells
08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

Epigenetic regulation of cancer-associated genes in ovarian cancer

Mi Jeong Kwon1, Young Kee Shin

  • 1Advanced Institutes of Convergence Technology, Suwon, Kyeonggi-do 443-270, Korea;

International Journal of Molecular Sciences
|May 5, 2011
PubMed

Insights

Epigenetic changes, specifically derepression, drive ovarian cancer by activating cancer-promoting genes. Understanding these epigenetic mechanisms is key for developing new therapies and early detection biomarkers.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Epigenetic aberrations are crucial in tumor development and progression.
  • Most research focuses on epigenetic inactivation of tumor suppressor genes, with less known about epigenetic activation of cancer-associated genes.
  • DNA hypomethylation is one known mechanism for epigenetic gene activation in cancer.

Purpose of the Study:

  • To review epigenetic mechanisms regulating cancer-associated genes in ovarian cancer.
  • To explore the role of epigenetic derepression in activating cancer-associated genes.
  • To discuss potential epigenetic therapies for ovarian cancer.

Main Methods:

  • Literature review of epigenetic mechanisms in ovarian cancer.
  • Analysis of recent findings on histone modifications and gene expression.
  • Discussion of therapeutic strategies targeting epigenetic dysregulation.

Main Results:

  • Overexpression of cancer-promoting genes in ovarian cancer correlates with loss of repressive histone modifications.
  • Epigenetic derepression is a potential mechanism for oncogene activation in ovarian tumors.
  • Epigenetically regulated genes represent promising therapeutic targets and biomarkers for ovarian cancer.

Conclusions:

  • Epigenetic derepression contributes to ovarian tumorigenesis by activating cancer-promoting genes.
  • Understanding epigenetic changes is crucial for identifying early detection biomarkers and novel therapeutic targets.
  • Targeting epigenetically dysregulated genes offers potential for improved ovarian cancer treatment and patient outcomes.
Keywords:
DNA methylationcancer-initiating cellschemoresistanceepigenetic derepressionepigenetic therapyhistone modificationmiRNAovarian cancer

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...